CHChristopher R. Honey

Christopher R. Honey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christopher R. Honey has a total of 167 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Network-Based Deep Brain Stimulation Rescue After Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for Essential Tremor: Two Targeting Strategies

    by Francisco Aranda Godoy, Evan Wilson, Danielle Pietramalla, Christopher R. Honey, Stefan Lang

    Background: Tremor may recur after magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy, and the optimal target for deep brain stimulation (DBS) rescue remains uncertain. Cases: A 71-year-old man with recurrent essential tremor after ventral intermediate nucleus (Vim) MRgFUS underwent DBS along a Vim-posterior subthalamic area (PSA) trajectory. Microelectrode activity was attenuated in the lesioned thalamus; Vim test stimulation was ineffective, whereas PSA stimulation suppressed tremor. A 79-year-old man with recurrent tremor after staged bilateral MRgFUS underwent left DBS targeting the rubral wing. Conclusions: When the original thalamic target is anatomically or physiologically altered, targeting intact cerebellothalamic pathways provides a rational rescue strategy. Highlights Deep brain stimulation can remain effective after failed focused ultrasound thalamotomy. These cases illustrate a lesion-informed, network-based strategy that preserves access to the cerebellothalamic network when prior lesioning has altered local anatomy or physiology.

  • Location of Neurostimulation Affects Short-Term Emotional Wellbeing Outcomes in Parkinson’s Disease Patients

    by Muhammad Faran, Hailey Chae, Danielle A. Pietramala, Sabrina Nadeem, Franziska A. Schmidt, Evan Wilson, Nancy E. Polyhronopoulos, Mandeep K. Sandhu, Jessica Dong, Natasha Sarai, et al.

    Introduction: Emotional wellbeing is a major determinant of quality of life (QoL) in Parkinson’s disease (PD) patients. Previous studies have found mixed results regarding the effect of subthalamic nucleus (STN) deep brain stimulation (DBS) on depression and anxiety, major contributors to emotional wellbeing. There is evidence that the location of neurostimulation of the STN may explain this variability. However, studies investigating this matter have also yielded inconsistent findings. Therefore, the objective of this study was to determine the effect of STN DBS on emotional wellbeing at 6 months and 1 year and to examine whether the location of neurostimulation influences outcomes. Methods: This is a retrospective cohort study of 94 patients who received bilateral STN DBS between 2008 and 2023 in Vancouver, Canada. Emotional wellbeing was assessed using the emotional wellbeing index (EWI) of the Parkinson’s disease questionnaire-39 (PDQ-39). We divided the EWI into sub-domains assessing anxiety (EWI-A) and depression (EWI-D). We analyzed clinical outcomes using linear mixed-effect models, controlling for confounding variables. We separated the group into responders and non-responders for further analysis. For subjects with appropriate imaging (n = 18), volume of tissue activated was calculated and related to clinical outcomes, to assess for a location that led to a significant improvement in EWI, EWI-A, and EWI-D. Results: We found no significant difference in EWI at 6 months and 1 year after STN DBS at the group level. There was a significant improvement in EWI-A at 6 months (p < 0.001) and 1 year (p = 0.045). No significant difference in EWI-D was observed at either time point. 37.1% of patients in our cohort were EWI responders, while 62.9% were non-responders. Similarly at 1 year, 35.7% of patients were responders and 64.3% were non-responders. Stimulation of the dorsal STN was associated with improved EWI outcomes at 6 months, but not at 1-year (p < 0.05 FWE corrected). Conclusion: There is significant variability in EWI outcomes following STN DBS. In the imaging analysis subgroup, stimulation of the dorsal region of the STN explained some of this variability in the short-term. Improvement in motor symptoms due to DBS may be a mediating variable between location of neurostimulation in the dorsal STN and improvements in emotional wellbeing.

  • Open Access

    Facial lymphatic malformation: the root cause of trigeminal neuralgia is not its root. Illustrative case

    by Intouch Sopchokchai, Benjamin K. H. Ho, Andrius Radziunas, Stefan T. Lang, Manraj K. S. Heran, Christopher R. Honey

    BACKGROUND: Trigeminal neuralgia (TN) is commonly caused by a vascular compression of the trigeminal nerve (classical TN). Due to the high frequency of this compression at the nerve’s root entry zone, a misunderstanding has arisen in the literature that this location is the only site that can cause TN. The present case demonstrates that TN can be caused by compression anywhere along the nerve—even in the face. OBSERVATIONS: A 15-year-old female presented with medically refractory left TN. MRI revealed no neurovascular conflict at the root entry zone, but ultrasound revealed a lymphatic malformation in her face. After the lesion was sclerosed with bleomycin, her TN pain improved significantly. LESSONS: Trigeminal nerve compression distal to the root entry zone, although uncommon, is a treatable cause of TN. Treatment for classical TN should consider the full anatomical course of the nerve and potential compression points. This case challenges the conventional understanding that TN is exclusively caused by compression at its more vulnerable root entry zone. https://thejns.org/doi/10.3171/CASE25973

  • Open Access

    Diagnosing Hemi-Laryngopharyngeal Spasm: Avoiding Unnecessary Tracheostomies

    by Andrius Radziunas, Francisco Aranda Godoy, Benjamin Ho, Intouch Sopchokchai, Shubhi Singh, Christopher R. Honey

  • Open Access

    Amelioration of acquired stuttering following thalamic deep brain stimulation

    by Phoebe Matthews, Intouch Sopchokchai, Aisha Alkubaisi, Benjamin Ho, Stefan Lang, Christopher R. Honey


  • Open Access

    The vagal rhizopathies

    by Christopher R. Honey

    Neurovascular compression of the tenth cranial nerve, the vagus nerve, can cause recognizable and neurosurgically treatable clinical conditions. This chapter will outline the clinical characteristics unique to vagus nerve compression and highlight both the definitive diagnostic protocol and neurosurgical treatment of these conditions. The vagus nerve has motor, sensory and autonomic components. Neurovascular compression of the motor component can cause hemi-laryngopharyngeal spasm (HELPS syndrome). Compression of the sensory component will cause a neurogenic cough called VANCOUVER syndrome – an acronym for Vagus Associated Neurogenic Cough Occurring due to Unilateral Vascular Compression of its Root. Both are caused by direct compression of the root of the tenth cranial nerve at the brainstem by a blood vessel and can be cured by microvascular decompression (MVD). Since the symptoms of choking and cough are common and blood vessels are often abutting the vagus nerve at the brainstem, it is vitally important to understand the definitive diagnostic protocol to avoid operating on false positives. Since the vagus nerve is far more susceptible to dysfunction during surgery than either the trigeminal or facial nerves, it is also important to understand the surgical nuances of this procedure.


  • Open Access

    Cordotomy under general anesthesia for a pediatric palliative patient: illustrative case

    by Franziska A Schmidt, Danielle A Pietramala, Christopher R Honey, Manraj K. S Heran

    BACKGROUND: Computed tomography (CT)–guided cordotomy has been shown to be a safe and effective method for treating cancer pain in adults in a palliative care setting. Its effectiveness has been rarely reported in children. During cordotomy, patient feedback is considered essential. Unfortunately, in this report, the featured patient’s age and demeanor precluded an awake cordotomy. The authors report the first case, to their knowledge, of percutaneous cordotomy with the patient under general anesthesia. OBSERVATIONS: An 11-year-old boy with osteosarcoma of the right pelvis presented with medically refractory unilateral nociceptive pain. The pain prevented ambulation, interfered with sleep, was the focus of his concern, and could not be relieved without sedation. A left percutaneous CT-guided cervical cordotomy while he was under general anesthesia was performed without complication and provided sufficient pain relief to allow ambulation and restorative sleep. Pain was no longer an issue for the patient and his family. LESSONS: CT-guided percutaneous cervical cordotomy can be accomplished in a pediatric patient under general anesthesia. The risks of cordotomy under general anesthesia without patient feedback must be weighed against the opportunity to improve palliative care. https://thejns.org/doi/abs/10.3171/CASE2427


  • Open Access

    Bilateral Anterior Capsulotomy for Treatment-Resistant Obsessive-Compulsive Disorder

    by Trevor Hurwitz, Geoffrey Ching, Nicholas Mark Bogod, Christopher R. Honey

    Introduction: Ablative surgery is an intervention of last resort for treatment-resistant obsessive-compulsive disorder (TROCD). Our center has been using bilateral anterior capsulotomy (BAC) for the past 20 years for patients eligible for limbic surgery. This report details our experience with BAC for TROCD. Method: Five patients with OCD met eligibility criteria for BAC. Entry protocols were complex and took around 6 months to complete. Stereotactic radiofrequency was used to produce the capsulotomies. Lesion length varied between 5.7 and 16.9 mm in the coronal plane. Patients were followed between 4 and 20 years. Results: All 5 patients (100%) were responders as defined by the widely accepted criteria of a reduction of ≥35% in Yale-Brown Obsessive Compulsive Scale (YBOCS) score at 18-month follow-up. Four patients remained responders at the 48 months. One patient was lost to follow-up. Responder status when viewed from the perspective of the YBOCS was sustained over the 4- to 20-year follow-up with one relapse 19 years postsurgery when medications were discontinued. Real-world psychiatric outcomes were different as other vulnerabilities surfaced illustrating the multifactorial determinants of mental health. No patient had any significant long-term neurocognitive or physical side effects. Conclusion: BAC should remain an option of last resort for patients with severe OCD who remain unresponsive to all other interventions.


  • Non-Motor Effects of Low-Frequency Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson’s Disease: A Systematic Review

    by Kenneth Ong, Franziska Schmidt, Kira Tosefsky, Muhammad Faran, Can Sarica, Christopher R. Honey, Fidel Vila-Rodriguez, Stefan Lang

    Introduction: Deep brain stimulation of the subthalamic nucleus is an effective therapy for the motor symptoms of Parkinson’s disease (PD). Typically, stimulation is applied at a high frequency (≥100 Hz) to alleviate motor symptoms. However, the effects on non-motor symptoms can be variable. Low-frequency oscillations are increasingly recognized as playing an important role in the non-motor functions of the subthalamic nucleus. Therefore, it has been hypothesized that low-frequency stimulation of the subthalamic nucleus (<100 Hz) may have a direct effect on these non-motor functions, thereby preferentially impacting non-motor symptoms of PD. Despite important therapeutic implications, the literature on this topic has not been summarized. Method: To understand the current state of the field, we performed a comprehensive systematic review of the literature assessing the non-motor effects of low-frequency stimulation of the subthalamic nucleus in PD. We performed a supplementary meta-analysis to assess the effects of low- versus high-frequency stimulation on verbal fluency outcomes. Results: Our search returned 7,009 results, of which we screened 4,199 results. A total of 145 studies were further assessed for eligibility, and a total of 21 studies met our inclusion criteria, representing 297 patients. These studies were a mix of case reports and control trials. The four clinical outcomes measured were sleep, sensory perception, cognition, and mood. A supplementary meta-analysis of six studies investigating the impact of low-frequency stimulation on verbal fluency did not find any significant results when pooling across subgroups. Conclusion: LFS of the STN may have benefits on a range of cognitive and affective symptoms in PD. However, current studies in this space are heterogeneous, and the effect sizes are small. Factors that impact outcomes can be divided into stimulation and patient factors. Future work should consider the interactions between stimulation location and stimulation frequency as well as how these interact depending on the specific non-motor phenotype.


  • Open Access

    Ventral targeted anterior capsulotomy for treatment-resistant depression and obsessive-compulsive disorder: A treatment method with cases

    by Trevor A. Hurwitz, Josue M. Avecillas-Chasin, Nicholas M. Bogod, Christopher R. Honey